Wait But Why, April 2016, “Why Cryonics Makes Sense” – This is probably now the most read piece in history about the pros and cons of cryonics. It was republished with permission in our magazine. Eight months later, our website still gets decent traffic from this article, and no link roundup would be complete without it. If you’re looking for one article to share with a friend who hasn’t thought about the issue, this is it.
MIT Technology Review, October 19, 2015, “The Science Surrounding Cryonics” – If you haven’t already seen the study from a year ago involving memory retention in cryopreserved roundworms, you should. This article links to that study as part of a longer discussion about cryonics and consciousness.
The Journal of Medical Ethics, February 25, 2015, “The case for cryonics” – I hate linking to articles behind a paywall, but if you’re looking for a thorough treatment of this topic, here it is.
Journal of Critical Care, December 2014, “The Future of Death” – An excellent piece on the changing nature of the boundary between life and death. “If future technologies come to include nanotechnological interventions to enter cells and reverse structural and molecular changes that prevent natural return to normal cell function, then even neuronal cell death as currently understood is not a loss of the capacity to return to consciousness. Whether a patient is living or dead depends on time, place, and circumstances as much as it does on biology.”
When we put out a call in mid-October for potential new Directors and Advisors, we were not expecting such a strong response. A good number of intelligent, talented, and experienced individuals stepped forth.
We are glad to announce that at the December 17, 2016 Alcor Board meeting, two individuals were invited to join the Alcor Board of Directors, and six individuals were invited to join the Advisors to the Board. This expands the Alcor Board from six to eight persons, leaving open one place. Welcome to Michael O’Neal, PhD and Andy Aymeloglu, who we believe will add tremendous value to the Board.
Welcome also to six new Advisors to the Board: Michael Anzis, Linda Chamberlain, David Kremelberg, PhD, James Miller, PhD. JD, James Ryley, PhD, and Robert Wilkes, PhD. Review of respondents is still underway, so additional Advisors may be appointed on a rolling basis.
Member A-1175, a neurocryopreservation member of many years standing, was found clinically dead on August 19, 2016. On Friday, August 26, 2016, he arrived at Alcor on dry ice and became Alcor’s 148th patient at the age of 68.
WHEN: October 23rd, 4:00 pm
WHERE: Cypress Point Lakes Condominium Complex
505 Cypress Point Dr., Mountain View, CA
HOST: Mark Galeck – phone 650-772-1251
Please bring food, we always have a potluck at the meetings. You can also bring a swimsuit and towel, there is sauna here and hot-tub. It takes a while to get the heat going in the clubhouse, so if it is cold outside, it will be cold inside for a little while – so bring some warm clothing.
New case report published on a case that occurred at the very end of 2015. Full report A-2889 Case Report.
At the 2016 Annual Meeting, cryopreservation minimums were left unchanged, remaining at the levels set in 2011. These minimums remain:
Neuro: $80,000 (or $100,000 to receive a waiver of the $180/year Comprehensive Member Standby fee).
Whole Body: $200,000 (or $220,000 to receive a waiver of the $180/year CMS fee).
Look for an article in Cryonics magazine in the near future on likely trends in cryopreservation minimums in the near future and in the longer term.
In recent years, Alcor has introduced discounts in membership dues for long-term members. Effective immediately, a new dues discount has been introduced. Anyone who has been a member for 40 years or longer will have their dues reduced to $60 per year ($15/quarter). This is around 11% of the current full rate for a first family member. This proposal, made by the president and passed unanimously by the board, is intended to build on previous discounts for long-term members and to reassure loyal members that their financial burden will fall over time.
Here are the results of the elections at the Alcor Annual Meeting on September 10, 2016:
After serving as a board member since 2001, Saul Kent did not stand for re-election, but remains an Alcor Advisory Board member. Alcor is grateful for his many years of service and activism, and for his key role in supporting development of technologies and companies vital to modern cryonics. Saul Kent’s support and promotion go back to within a few years of Alcor’s founding in 1972. Saul was the principal organizer and Director of Alcor’s first conference in 1978. In the 1980s he helped fund Alcor’s operations and research, and participated in and funded pivotal legal battles. During the 1990s, Saul established companies that developed the core technologies used by Alcor for stabilization, cryopreservation, and storage. After rejoining Alcor’s board in 2001, Saul established Suspended Animation, Inc., and continued to provide financial and legal support. Finding and hiring Alcor’s CEO Max More was another accomplishment directly attributable to Saul’s initiative and support.
All other directors were unanimously re-elected:
President: Max More was re-relected unanimously.
CFO/treasurer: Michael Perry was re-relected unanimously.
Secretary: Michael Perry was re-relected unanimously.
The public portion of the Annual Meeting will take place on Saturday September 10. The public board meeting is expected to start later than standard. The public sessions are expected to run from 11:45 am to 2:45 pm on Saturday. The public part of the meeting will include officer and director elections and board reports.